Clover Health Investments, Corp. CLOV shares are trading higher on Tuesday. Shares has been volatile over the course of November. Here's a look at what's been moving the stock.
What To Know: Shares of Clover Health Investments rallied in early November ahead of the company's third-quarter earnings report. The company reported its financial results on Nov. 6, posting quarterly sales of $482.07 million, missing the analyst consensus estimate of $494.60 million, and an earnings loss of nine cents per share, which exceeded analyst expectations of losses of 11 cents.
Shares took a nosedive in the days following the results, although the stock has regained some ground on Tuesday. The gain may be due in part to overall market strength related to October CPI data which indicated that U.S. inflation abated during the month.
Related Link: Novo Nordisk's Ozempic Usage Suspended - Belgium Implements Temporary Ban Amid Medication Shortage
CLOV Price Action: Shares of CLOV were up 11.1% at $1.00 at the time of publication, according to Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
